Harry Simeonidis - Intelligent Bio President CEO
| INBS Stock | USD 1.60 0.03 1.84% |
CEO
Harry Simeonidis is President CEO of Intelligent Bio Solutions
| Age | 56 |
| Address | 135 West, 41ST Street, New York, NY, United States, 10036 |
| Phone | 646 828 8258 |
| Web | https://ibs.inc |
Intelligent Bio Management Efficiency
The company has return on total asset (ROA) of (0.5326) % which means that it has lost $0.5326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7171) %, meaning that it created substantial loss on money invested by shareholders. Intelligent Bio's management efficiency ratios could be used to measure how well Intelligent Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.13 in 2024. Return On Capital Employed is likely to gain to -1.17 in 2024. At this time, Intelligent Bio's Other Current Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 1 M in 2024, whereas Total Current Assets are likely to drop slightly above 6.5 M in 2024.Similar Executives
| Showing other executives | CEO Age | ||
| Nick Emery | WPP PLC ADR | N/A | |
| Michael Houston | WPP PLC ADR | N/A | |
| Brent CPA | KVH Industries | 58 | |
| Jon Cook | WPP PLC ADR | N/A | |
| Mark CBE | WPP PLC ADR | 58 | |
| Christian Juhl | WPP PLC ADR | N/A | |
| Donna Imperato | WPP PLC ADR | N/A | |
| Mel Edwards | WPP PLC ADR | N/A | |
| Mark Read | WPP PLC ADR | 57 | |
| Michael Christenson | Entravision Communications | 65 | |
| Toby Jenner | WPP PLC ADR | N/A | |
| Ajaz Ahmed | WPP PLC ADR | N/A | |
| Richard Glasson | WPP PLC ADR | N/A | |
| John Seifert | WPP PLC ADR | N/A | |
| Andy Main | WPP PLC ADR | N/A | |
Management Performance
| Return On Equity | -1.72 | ||||
| Return On Asset | -0.53 |
Intelligent Bio Solutions Leadership Team
Elected by the shareholders, the Intelligent Bio's board of directors comprises two types of representatives: Intelligent Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelligent. The board's role is to monitor Intelligent Bio's management team and ensure that shareholders' interests are well served. Intelligent Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelligent Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BBus CA, Chief Officer | ||
| Harry Simeonidis, President CEO | ||
| Alex Arzeno, VP Relations | ||
| Victoria Gavrilenko, Operations Manager |
Intelligent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intelligent Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.72 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (3.86) % | ||||
| Current Valuation | 3.84 M | ||||
| Shares Outstanding | 4.39 M | ||||
| Shares Owned By Insiders | 3.01 % | ||||
| Shares Owned By Institutions | 14.38 % | ||||
| Number Of Shares Shorted | 564.62 K | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 2.30 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.